nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Correction to Lancet Haematol 2024; 11: e459–70
|
|
|
|
11 |
7 |
p. e480 |
artikel |
2 |
Correction to Lancet Haematol 2024; 11: e310–11
|
|
|
|
11 |
7 |
p. e480 |
artikel |
3 |
Don Thomas: leading the charge to bone marrow transplantation
|
Burki, Talha |
|
|
11 |
7 |
p. e485-e486 |
artikel |
4 |
Evolution, and current and future role of radiotherapy in the treatment of haematological malignancies
|
Specht, Lena |
|
|
11 |
7 |
p. e476-e479 |
artikel |
5 |
Iadademstat in combination with azacitidine in patients with newly diagnosed acute myeloid leukaemia (ALICE): an open-label, phase 2a dose-finding study
|
Salamero, Olga |
|
|
11 |
7 |
p. e487-e498 |
artikel |
6 |
Infected blood scandal linked to more than 3000 deaths
|
Gourd, Elizabeth |
|
|
11 |
7 |
p. e481-e482 |
artikel |
7 |
Local radiotherapy and measurable residual disease-driven immunotherapy in patients with early-stage follicular lymphoma (FIL MIRO): final results of a prospective, multicentre, phase 2 trial
|
Pulsoni, Alessandro |
|
|
11 |
7 |
p. e499-e509 |
artikel |
8 |
Measurable residual disease-driven therapy after radiotherapy for early-stage follicular lymphoma
|
Gunther, Jillian R |
|
|
11 |
7 |
p. e472-e473 |
artikel |
9 |
Molecular diagnosis of primary CNS lymphoma in 2024 using MYD88 Leu265Pro and IL-10
|
Calimeri, Teresa |
|
|
11 |
7 |
p. e540-e549 |
artikel |
10 |
Obiageli Nnodu: sickle cell disease in Africa's largest nation
|
Cavanaugh, Ray |
|
|
11 |
7 |
p. e483 |
artikel |
11 |
Pembrolizumab and low-dose, single-fraction radiotherapy for patients with relapsed or refractory multiple myeloma: a prospective, single-centre, single-group, open-label, phase 2 pilot trial in the USA
|
Khan, Mohammad K |
|
|
11 |
7 |
p. e510-e520 |
artikel |
12 |
Pembrolizumab plus single-fraction radiotherapy for patients with relapsed or refractory multiple myeloma
|
Suzuki, Kenshi |
|
|
11 |
7 |
p. e473-e475 |
artikel |
13 |
Response-adapted ultra-low-dose 4 Gy radiation as definitive therapy of gastric MALT lymphoma: a single-centre, pilot trial
|
Gunther, Jillian R |
|
|
11 |
7 |
p. e521-e529 |
artikel |
14 |
The development of academic CAR T cells
|
Delgado, Julio |
|
|
11 |
7 |
p. e484-e485 |
artikel |
15 |
The evolutionary journey from essential thrombocythaemia to acute erythroid leukaemia
|
Borsani, Oscar |
|
|
11 |
7 |
p. e550 |
artikel |
16 |
The origin of ferritin reference intervals: a systematic review
|
Truong, Judy |
|
|
11 |
7 |
p. e530-e539 |
artikel |
17 |
UK tainted blood: amplifying the voices of the victims
|
The Lancet Haematology, |
|
|
11 |
7 |
p. e471 |
artikel |
18 |
Ultra-low-dose radiation for gastric MALT lymphoma
|
Petersen, Peter Meidahl |
|
|
11 |
7 |
p. e475-e476 |
artikel |